Search Medical Condition
Please enter condition
Please choose location

Irritable Bowel Syndrome (IBS) Clinical Trials

A listing of Irritable Bowel Syndrome (IBS) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (55) clinical trials

A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients with Irritable Bowel Syndrome with Constipation (IBS-C)

Phase

SP304203-04 : Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients with Irritable Bowel Syndrome with Constipation (IIBS-C).

Phase N/A

HWC Women's Research Center is conducting a 12 week clinical research study of an investigational medication for IBS-C. You may qualify for: Investigational Medication Study-related labs and care Reimbursement for time and travel

Phase N/A

The purpose of this study is to confirm the sensitivity and specificity of the BUHLMANN fCAL ELISA in patients, as an aid in diagnosis to differntiate between Inflammatory Bowel Disease (Crohn's Disease, Ulcerative Colitis, or indeterminate colitis) and Irritable Bowel Syndrome.

Phase N/A

A 12-week research study to test the safety and effectiveness of an investigational medication for the treatment of Irritable Bowel Syndrome with Constipation.

Phase

To evaluate the safety, efficacy, and dose response of 2 different delayed release formulations of Linaclotide administered orally to patients with irritable bowel syndrome.

Phase

Men or women 18-75 years of age Abdominal discomfort Constipation Up to $600 for time and travel

Phase N/A

During the 12-week treatment period, subjects will record daily assessments including: frequency and timing of bowel movements; sensation and complete bowel emptying; consistency of bowel movements; degree of straining, worst abdominal pain, abdominal discomfort, abdominal bloating, abdominal fullness and abdominal cramping. Subjects will also record weekly assessments including: adequate relief ...

Phase

A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor (study medication) for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C).

Phase